Would you like to present your abstract


Call for Oral Presentations!


  • Abstract’s submission deadline for Oral Presentation is 6 December 2017
  • If you are applying for the FCP scholarships deadline is 15 November 2017
  • The scientific committee will consider to accept as Poster the abstracts not accepted for Oral Presentations
  • Presenting authors of accepted abstracts for Oral Presentation will be notified whether their abstract is accepted by January 15th 2018.
  • Oral presentation speakers must pay their registration to the congress by January 23th 2018. Failure to do so, will result in exclusion from the programme and the Book of Abstracts.

for Posters!


  • Abstract’s submission deadline for Posters is 11 January 2018
  • Presenting authors of accepted abstracts for Poster Presentation will be notified whether their abstract is accepted by January 15th 2018.
  • If you are applying for the FCP scholarships deadline is 15 November 2017
  • Poster presenters must pay their registration to the congress by January 23th 2018. Failure to do so, will result in exclusion from the programme and the Book of Abstracts.

How should I write my abstract?

  • The abstract must be divided into the following sections:
    ContextObjectiveMethods Patient(s) Intervention(s) Main Outcome Measure(s) Result(s) Conclusions.
  • The abstract cannot be longer than 2500 characters including spaces, and must be plain text: it is not possible to include tables and images, but you may insert data in the text of the abstract.
  • Each person is allowed to submit a maximum of two abstracts on the congress’ topics as presenting author: one oral presentation and one poster or, alternatively, two posters. There is no limit to the number of abstracts submitted as co-author

Submit your abstract


Gynecological endocrinology

1.1 Regulation of the HPA axis
1.2 FSH and LH receptors
1.3 Hyperprolactinemia
1.4 GnRH analogues and antagonists
1.5 Steroids and steroid receptors signaling mechanisms
1.6 Biological actions of progestins
1.7 Androgens and hyperandrogenisms
1.8 Primary and secondary amenorrhea 1.9 Polycystic ovary syndrome
1.10 Insulin resistance
1.11 Obesity and metabolic syndrome
1.12 Pediatric and adolescent endocrinology
1.13 Thyroid diseases
1.14 Endocrine disorders and woman’s health
1.15 Endocrine disruptors
1.16 Selective steroid receptor modulators


2.1.New compounds for contraception
2.2. Non-contraceptive benefits of contraceptives
2.3. Male contraception
2.4. Emergency contraception
2.5. Medical and surgical abortion
2.6. Intrauterine contraceptives
2.7.Contraception and adolescents
2.8.Contraception and perimenopause
2.9.Therapeutic uses of hormonal contraceptives
2.10. Long lasting contraception

Medically assisted procreation

3.1 Embryo implantation and development
3.2 Stem cells and human reproduction
3.3 Mechanisms of follicle selection and development
3.4 Reproduction, the Immune system and oxidative stress
3.5 The infertile couple
3.6 Techniques in medically assisted procreation
3.7 Ovulation induction
3.8 Ovarian hyperstimulation
3.9 Endometriosis and assisted reproduction
3.10 The anovulatory patient
3.11 Endocrine disorders and medically assisted procreation
3.12 Adnexal diseases and medically assisted procreation
3.13 Fertility preservation
3.14 Autologue and heterologue donation
3.15 MAP and ethics
3.16 MAP in premature ovarian insufficiency
3.17Time Laps


4.1 Recurrent abortion
4.2 Extra-uterine pregnancy
4.3 Prenatal diagnosis
4.4 Prenatal medicine
4.5 The placenta and the fetal membranes
4.6 The thyroid and pregnancy
4.7 Immunological disorders and pregnancy
4.8 Endocrine disorders in pregnancy
4.9 Neurodegenerative disorders in pregnancy
4.10 Insulin resistance and obstetric diseases
4.11 Obesity and fetal and maternal risks
4.12 Pregnancy and lifestyle
4.13 Preterm labor and delivery
4.14 Gestational hypertension, pre-eclampsia and eclampsia
4.15 Gestational Diabetes Mellitus
4.16 Normal and abnormal intrauterine growth
4.17 Infectious diseases and pregnancy
4.18 Twin and multiple pregnancies
4.19 Labor induction
4.20 Caesarean Section: pro and con
4.21 Fetal origins of adult diseases
4.22 Postpartum management of high risk pregnancies


5.1 Stem cells in gynecology
5.2 Angiogenesis and gynecological diseases
5.3 Puberty and adolescent gynecology
5.4 Female sexual function and dysfunction
5.5 Sexually transmitted diseases
5.6 Hormones and gynecological disorders
5.7 Endometrial regulation
5.8 Abnormal uterine bleeding
5.9 Pelvic pain
5.10 Endometrial hyperplasia
5.11 Endometriosis: genetics and hormones
5.12 Medical treatments for endometriosis
5.13 Uterine myomas, medical and surgical management
5.14 Clinical management of simple adnexal cysts
5.15 Vulvar and vaginal lesions

Menopause and ageing

6.1 Steroid hormones and ageing
6.2 Neurotoxicity, neuronal survival and hormone protection
6.3 The climacteric syndrome
6.4 Menopause, HRT and CVD
6.5 Menopause, HRT and cancers
6.6 Menopause, HRT and neurodegenerative diseases
6.7 Postmenopausal osteoporosis
6.8 Bisphosphonates, PTH and the bone-forming agents
6.9 Selective estrogen receptor modulators SERM’s
6.10 Progesterone, progestins SPRM’s
6.11 Androgen therapy
6.12 Bio-identical treatments
6.13 Non-hormonal treatments for climacteric women
6.14 Sexual health and dysfunction

Submit your abstract

Gynecological oncology

7.1 Genes and gynecological cancers
7.2 Hormones and gynecological cancers
7.3 Stem cells and gynecological malignancies
7.4 Proteomics for cancer diagnosis and treatment
7.5 Screenings and for gynecological cancers
7.6 HPV and HPV vaccines
7.7 Border-line and pre-tumoral lesions
7.8 Clinical management of gynecological cancers
7.9 Conservative approaches to gynecological cancers
7.10 New concepts in radio/chemotherapy
7.11 Hormonal therapies for gynecological cancers
7.12 Pregnancy and cancer

The breast

8.1 Breast development and function
8.2 Hormones and the breast
8.3 Benign breast diseases, contraception
and HRT
8.4 Breast carcinogenesis
8.5 Hormones, breast cancer proliferation
and metastasis
8.6 New prognostic and predictive factors
8.7 Anti-estrogens, SERMs and aromatase inhibitors
8.8 Oncological and aesthetic breast surgery
8.9 Breast cancer and pregnancy

Gynecological surgery

9.1 Vaginal approaches to pelvic diseases
9.2 Urinary incontinence
9.3 New techniques for pelvic floor defects correction
9.4 Laparoscopic treatment of pelvic masses
9.5 Laparoscopy, endometriosis and reproduction
9.6 New treatments of uterine myomas
9.7 Sentinel node biopsy in gynecological cancers
9.8 Oncological applications of laparoscopy
9.9 Robotic surgery in gynecology
9.10 Multidisciplinary approach to the pelvic floor


10.1 Ultrasound in gynecology and obstetrics
10.2 Interventional ultrasound techniques
10.3 Hysteroscopy
10.4 Colposcopy
10.5 Laparoscopy


100 Full Congress package (FCP)

Deadline extended to 15 November

  • Pre-Congress course
  • Congress Registration
  • Hotel accommodation

There are 100 scholarships available to cover costs relating to the pre-Congress Course, Congress registration and hotel accommodation from 6 to 10 March*. The Scientific Committee will select 100 abstracts deemed to be “of particular interest” from those submitted. The presenting author will be granted the scholarship (one author per abstract).
*The accommodation provided will be a twin room in a 3-star hotel; the dates of the stay may not be changed.


  • applicants must be a trainee or postdoctoral researcher under the age of 35;
  • applicants must submit an abstract for which they are the primary author before 31 October 2017 15 November;
  • when submitting the abstract, applicants must tick the ‘100 FCP Scholarships’ box and submit a certificate to prove their trainee/postdoctoral status.

Free congress registrations

  • Congress Registration


  • applicants must be a trainee and submit an abstract for which they are the primary author;
  • abstracts must be accepted as an Oral or Poster presentation to be eligible;
  • applicants must certify their trainee status.

Reduced registration fees

  • Attend the Congress thanks to a reduced registration fee (350€).


  • applicants must submit and present one or more abstracts at the Congress;
  • the abstract must be accepted as an Oral or Poster presentation to be eligible.

Submit your abstract